Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
212 studies found for:    "combined pituitary hormone deficiency" OR "Hypopituitarism"
Show Display Options
Rank Status Study
21 Completed Effect of 5 Years of GH Replacement on Atherosclerosis
Conditions: Hypopituitarism;   Pituitary Tumors;   Growth Hormone Deficiency
Intervention: Drug: Recombinant Growth Hormone, Genotropin (Pfizer)
22 Completed
Has Results
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency;   Septo-Optic Dysplasia;   Hypopituitarism
Intervention: Drug: Nutropin AQ
23 Completed Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
Conditions: Secondary Hypothyroidism;   Hypopituitarism;   Hyperlipidemias
Intervention: Drug: Thyroxin, Triiodothyronine
24 Recruiting Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Conditions: Hypopituitarism;   Hypogonadism;   Thyroid Dysfunction;   Bone Diseases, Metabolic
Intervention:
25 Completed Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages
Conditions: Brain Injuries;   Intracranial Aneurysm
Intervention:
26 Completed Growth Hormone and Endothelial Function in Children
Conditions: Growth Hormone Deficiency;   Panhypopituitarism;   Short Stature
Intervention: Drug: growth hormone
27 Not yet recruiting Pubertal Induction in Individuals With Hypogonadism
Conditions: Primary Amenorrhoea;   Hypothalamic Amenorrhoea;   Hypogonadotrophic Hypogonadism;   Hypopituitarism;   Turner's Syndrome;   Primary Ovarian Insufficiency
Intervention: Drug: Routine transdermal oestrogen patch
28 Recruiting Lipolytic Effects of GH in Hypopituitary Patients in Vivo
Conditions: Hypopituitarism;   Insulin Resistance;   Endocrine System Diseases;   Glucose Metabolism Disorders;   Metabolic Diseases;   Pituitary Diseases;   Brain Diseases
Interventions: Drug: Acipimox;   Drug: Placebo;   Drug: GH substitution;   Other: GH pause
29 Enrolling by invitation Central Hypothyroidism, a Novel Laboratory Measurement
Condition: Central Hypothyroidism
Intervention: Drug: Eltroxin
30 Recruiting Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries
Condition: Moderate to Severe Traumatic Brain Injury
Intervention: Other: Biological and behavioral explorations
31 Recruiting Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury
Condition: Traumatic Brain Injury (TBI)
Intervention: Other: MRI scan and endocrinology analysis
32 Completed VRS-317 in Adult Subjects With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: VRS-317
33 Recruiting Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
Condition: Hypogonadotropic Hypogonadism
Intervention: Drug: Gonadotropin-releasing Hormone
34 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
35 Completed A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
Conditions: Dwarfism;   Growth Hormone Deficiency
Intervention: Drug: r-hGH
36 Completed Observational Study of Somatropin Treatment in Children
Conditions: Dwarfism, Growth Hormone Deficiency;   Turner Syndrome;   Infant, Small for Gestational Age;   SHOX Protein, Human
Intervention: Drug: Somatropin (rDNA origin)
37 Completed
Has Results
Genotropin Study Assessing Use of Injection Pen
Conditions: Growth Hormone Deficiency;   Idiopathic Short Stature
Intervention: Device: New Genotropin Pen
38 Completed
Has Results
Drug Use Investigation of Somatropin for GHD-ADULTS.
Condition: Dwarfism, Growth Hormone Deficiency
Intervention: Drug: Somatropin
39 Unknown  Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
Conditions: Pseudohypoparathyroidism;   Growth Hormone Deficiency, Dwarfism
Intervention: Drug: recombinant human somatotropin
40 Completed rhGH Therapy on Hepatic Drug Metabolism
Condition: Growth Hormone Deficiency, Dwarfism
Intervention: Drug: Dextromethorphan and Caffeine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.